AGENUS INC — Director's Dealing 2022

Feb 4, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGENUS INC (AGEN)
CIK: 0001098972
Period of Report: 2022-02-02

Reporting Person: O'Day Steven J (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-02-02	Common Stock	A	101682	$2.51	Acquired	163003	Direct

Footnotes

F1: Reflects the executive's 2021 performance bonus award paid in Agenus Stock. The stock issued is fully-vested on the date of issuance but is subject to a 6-month lockup restriction with 25% of the award released on the 3-month anniversary of the issuance date and 75% of the award released on the 6-month anniversary.

F2: $2.51 was the fair market value of our Common Stock on February 2, 2022, the stock issuance date.